PTL Enterprises Ltd Company Summary

42
(-0.64%)
Jul 23, 2024|03:32:39 PM

PTL Enterprises Ltd Summary

PTL Enterprises Ltd , (formerly known as Premier Tyres Ltd.) was incorporated in 1959. The tyres manufacturing facility of PTL at Kalamassery, Kerala, is leased out to ApolloTyres Limited on long term basis. All production is done by Apollo Tyres Limited.The company was declared a sick unit by the Board for Industrial and Financial Reconstruction (BIFR) and under a rehabilitation scheme prescribed by the Board, PTL was taken over by Apollo Tyres in 1995. This involved Apollo subscribing to Premiers additional equity of Rs 10 cr at par. The authorised capital of the company has increased from Rs 4 cr to Rs 14 cr and its registered office shifted from Mumbai to Cochin. According to the BIFR order, Apollo will operate Premiers plant on an irrevocable lease of 8 years and pay a total lease rental amounting to Rs 45.50 cr to Premier Tyres. Apollo will lift the entire production of Premier and sell the same under the Apollo brand name.The Companys first super specialty hospital project in Gurgaon, by the name of Artemis Health Institute (AHI) was started in July 2007. A new 47 bedded Hospital unit in the name and style of Artemis Hospital at Dwarka, New Delhi commenced operations in September 2012. During 2012-13, PTL Projects Ltd., a wholly owned subsidiary of the Company, acquired 100% shareholding in Athena Eduspark Ltd. for expanding its activities into medical, management, professional and technical education etc.During 2015-16, name of the Subsidiary Company- PTL Projects Limited changed to Artemis Global Life Sciences Limited consequent to change in Object Clause from Projects Management to Medical & Healthcare Business. The Directors approved sale of 30, 25,000 Equity Shares held in Artemis Medicare Services Limited (AMSL) to Artemis Health Sciences Limited (AHSL) and consequently, AMSL became 100% subsidiary of AHSL w.e.f. 31 December, 2015. The Company increased investments in its wholly owned subsidiary company, Artemis Health Sciences Limited (AHSL), by subscribing 79.90 lacs shares of Rs.10/- each at a premium of Rs. 45 and accordingly, Companys holding in AHSL would remain 100%.The Board of Directors have approved to demerge the whole of Medicare and Healthcare Undertaking of PTL Enterprises Limited into its wholly owned subsidiary Artemis Global Life Sciences Limited- AGLSL (Formerly- PTL Projects Limited, name changed w.e.f 29th December, 2015) on a going concern basis. The Scheme of Demerger/Arrangement sanctioned by the Kerala High Court and National Company Law Tribunal, New Delhi between PTL Enterprises Ltd (the Demerged Company) and its wholly owned subsidiary, Artemis Global Life Sciences Ltd (AGLSL) (formerly known as PTL Projects Limited) (the Resulting Company) and their respective shareholders and the creditors of the two companies for demerger of the Medicare and Healthcare Services Business undertaking of the Demerged Company into Resulting Company was operative with the Appointed Date on 01st April 2016, and resulting to this, the Scheme became effective from 8th March 2017 through the Demerger Scheme. All the assets and liabilities of the Medicare and Healthcare Services Business undertaking got transferred as a going concern. Therefore, the Company ceased to be Holding Company of Artemis Health Sciences Ltd, Artemis Medicare Services Ltd, Artemis Global Life Sciences Ltd (Formerly PTL Projects Ltd) and Athena Eduspark Ltd. w.e.f 01st April 2016.

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.